Answers are grounded in this paper and cite their sources.
Finds significant antileukemic activity of 1,5-diaryl-1,4-pentadien-3-one derivatives in HL60 cells, suggesting potential for leukemia therapy.
BACKGROUND/AIM: ] using cell viability assay and induction of apoptosis. MATERIALS AND METHODS: The anticancer activity was checked against the HL-60 cell line using an MTT assay, followed by apoptotic assay, molecular docking, and molecular dynamics (MD) simulation studies. The Desmond simulation package of Schrodinger (v.2022-1) was employed to perform MD simulations analysis. RESULTS: and doxorubicin in complex with topoisomerase IIb indicated stabilization of the topoisomerase IIb complex over time. CONCLUSION: Naphthol AS-BI 2 exhibits significant antileukemic activity and warrants further investigation to explore its clinical potential in leukemia therapy.
No takes yet. Share an insight, caveat, or question.
Rehman et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: